RefinedScience is a platform and team of scientists, data experts, and clinicians focused on improving drug and diagnostic development. We connect clinical datasets, primary tissue analysis, and computational methods into a unified, decision-ready framework to generate insights that move programs forward with greater confidence. Our aim is to help create a future in which every drug and diagnostic development decision is informed by real human biology, resulting in higher success rates, accelerated timelines, and more effective therapies for patients.
| Website | https://www.refinedscience.com/ |
| Employees | 39 (32 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Clinical Trials, Clinical Research, Data Analysis, Healthcare Data, Drug Development, Patient Insights, Clinical Data, Trial Optimization, Medical Research, Biotechnology, Scientific Consulting, Data Integration, Healthcare Analytics, Precision Medicine, Biological Data, Life Sciences, Big Data Analytics, Expert Knowledge, Scientific Data, Biostatistics |
| Competitors | Cerevel Therapeutics, Axovant Sciences Ltd, Neurocrine Biosciences, Alnylam Pharmaceuticals, Voyager Therapeutics, Inc., Sarepta Therapeutics, Inc., bluebird bio, Abeona Therapeutics, Editas Medicine, CRISPR Therapeutics +39 more (view full list) |
Looking for a particular RefinedScience employee's phone or email?
Erik Johnson is the CEO of RefinedScience.
32 people are employed at RefinedScience.
RefinedScience is based in Aurora, Colorado.